Patients with chronic lymphocytic leukemia (CLL) may develop diffuse large B-cell lymphoma (DLBL), also known as Richter's syndrome. Mutational status of immunoglobulin (Ig) heavychain variable region (V H ) genes have prognostic impact in CLL. Patients with mutated V H genes have a stable disease, whereas patients with unmutated V H gene have more aggressive disease. The mutational status of CLLs that transform to DLBL is unknown. To reveal whether Richter's syndrome occurs in CLLs with mutated or unmutated V H genes, we have performed mutational analysis on serial specimens from eight patients. CLL and DLBL tumorclones were identical in five cases and they were different in three cases. Six CLLs expressed unmutated and two cases expressed mutated V H genes. In five of the six unmutated CLLs, the DLBL clones evolved from CLL tumorclones and the V H genes expressed by DLBLs were also unmutated. In one unmutated and two mutated CLLs, the DLBLs expressed mutated V H genes, but in these three cases the DLBL tumorclones developed as independent secondary neoplasm. These results suggest that Richter's syndrome may develop in both mutated or unmutated CLLs, but clonal transformation of CLL to DLBL occur only in the unmutated subgroup of CLL.
Introduction
Chronic lymphocytic leukemia (CLL) is characterized by a variable clinical course; some patients may survive for decades without treatment, others die from drug-resistant disease shortly after presentation. 1, 2 In approximately 5-10% of CLL patients, a diffuse large-cell lymphoma (DLBL) may develop over time. 3, 4 This process is commonly referred to as Richter's syndrome.
Recently, the mutational status of immunoglobulin heavychain (IgH) variable region (V H ) genes has been established as a crucial prognostic factor in CLL. It has been demonstrated that CLL comprises two subsets with either mutated or unmutated V H genes.
1,2 Cases expressing unmutated V H genes have a worse clinical course in terms of overall survival, requirement for treatment and progression to more advanced clinical stages than cases expressing mutated V H genes. Based on these studies, it has been postulated that CLLs are clinically, prognostically and pathogenetically two different diseases that probably differ in cell origin. 5 The characterization of molecular mechanisms associated with Richter's syndrome is a critical issue to understand the pathogenesis of these lymphomas. It has been demonstrated that DLBL may occur in two distinct pathways in CLL patients: CLL and DLBL can be either clonally related or represent clonally unrelated neoplasms; however, the high-risk variants of CLL that are prone to develop Richter's syndrome have not been determined. 6, 7 The V H gene sequences of CLL and DLBL samples have been analyzed in only four cases of Richter's syndrome: in a previous report, we found stable, unmutated V H sequences in a clonal progression of CLL to DLBL, 7 but Cherepakihin et al 8 demonstrated ongoing hypermutation in an another case, similar to transformation of follicular lymphoma to DLBL.
9,10 Nakamura et al 11 reported two cases of Richter's syndrome, where DLBL tumorclones expressed mutated V H genes, but these tumorclones were unrelated to the original CLLs. Unfortunately, a definitive conclusion can not be drawn from these results, because of the low number of cases analyzed.
To reveal whether Richter's syndrome occurs in CLLs with mutated or unmutated V H genes, we have performed a longitudinal V H gene analysis in sequential biopsy specimens from eight patients with Richter's syndrome. Our results indicate that clonal progression occurs in CLLs with unmutated V H genes, but secondary DLBLs as CLL independent tumorclone originate from mutated subset of B cells.
Materials and methods

Pathological samples
Peripheral blood, bone marrow or lymph node biopsy samples from eight patients who had CLL that progressed to DLBL were selected for this study based on the availability of frozen tissue for the molecular analyses. The clinical data of the patients are summarized in Table 1 . Diagnoses were based on histopathologic, immunophenotypic and immunogenotypic analyses according to the World Health Organization Classification of lymphoid tissues. 5 In all DLBL samples, the percentage of tumor cells were more than 90%. In all the eight cases, tumor cells of CLLs and corresponding DLBLs coexpressed CD5, CD19, CD20 and CD23 antigens.
Southern blot hybridization
Genomic DNAs were extracted from cryopreserved tissue samples using the salting out techniques. 12 . The IgH gene was investigated by hybridization of EcoRI-and HindIII-digested DNAs to an IgH joining region (J H ) probe as described previously. 7 PCR amplification, cloning and sequencing of the Ig V H sequences DNAs were amplified by PCR using sense V H gene familyspecific leader primers in conjunction with an antisense consensus J H primer in independent reactions. 13 PCR products were cloned in the pCR 2.1-TOPO Vector using the TOPO Cloning system (Invitrogen Corporation, San Diego, CA, USA). After the transformation of competent cells, colonies found to contain an insert of appropriate size by restriction analysis of plasmid DNA were sequenced by an automated DNA sequencer (Applied Biosystems, Foster City, CA, USA). In all samples, six sequences from independent bacterial isolates were analyzed. The sequences obtained were compared to the corresponding germline sequences using EMBL/GenBank database to estimate the respective homology of each gene with its closest germline counterpart. Where there was 42% derivation from a germline V H sequence, the Chang and Casali 14 formula was used to determine whether the replacement (R) mutation had undergone antigenic selection.
Results
Clonal relationship of the CLL and corresponding DLBL samples
The clonal relationship of the CLL and DLBL samples has been identified by Southern blot and nucleic acid sequence analysis of the IgH gene. All samples included in this study displayed monoclonal IgH gene rearrangement. In five cases (cases 1-5), the first and the corresponding second biopsy samples showed identical Southern blot patterns and V H -D-J H gene sequences, indicating the common clonal origin of the tumor samples. In three cases (cases 6-8), the first and second corresponding biopsy samples displayed different patterns of the Southern blot hybridization and different V H -D-J H gene sequences, indicating different clonal origin of the two tumors ( Table 2) .
Use of V H gene segments
The rearranged V H -D-J H sequences identified for each samples seemed to represent functional rearrangements because no stop codons or crippling mutations were identified. Comparing the V H genes to reported germline sequences revealed that four of the eight CLL cases used V H 1 family gene segments (cases 1, 3, 4 and 7), three used V H 3 family gene segments (cases 2, 5 and 6) and one case (case 8) used a gene segment from the V H 4 family. In five cases (cases 1-5), the DLBLs and corresponding CLLs used the same V H genes. In three cases (cases 6-8), DLBL samples used V H genes different from the corresponding CLL samples. Two of these three DLBLs (cases 6 and 8) used V H 3 family gene segments and one (case 7) used a V H 5 family gene ( Table 2) . 
V H gene somatic mutations
Based on the number of nucleotide differences from germline genes, the eight CLL cases could be divided into two groups. Samples in which fewer than 2% of base pairs differed from those of the consensus sequence for V H gene were considered unmutated (cases 1-6), whereas cases with more than 2% of base pairs differed from consensus V H gene sequence fell into the mutated group (cases 7 and 8). 1 In five cases of Richter's syndrome where CLL and the DLBL samples were identical (cases 1-5), V H genes were unmutated. In the three cases where CLL and corresponding DLBL samples were different (cases 6-8), the V H sequences of DLBL samples showed 91.8-96.9% homology to the closest germline gene sequences. None of the tumor samples showed evidence of intraclonal V H gene diversity.
Analysis of somatic mutations
In the absence of negative or positive selection pressure on a gene product, nucleotide changes yielding amino-acid replacement (R mutations) and nucleotide changes not yielding aminoacid replacement (S, or silent mutations) are randomly distributed throughout the coding sequence. If a DNA segment displays a number of R mutations higher than that expected by chance, it is likely that positive pressure was exerted on the gene product to select for these mutations. Conversely, if a DNA segment displays a number of R mutations lower than expected by chance, it is likely that positive pressure was exerted on the gene product to select against R mutations so that the protein structure is preserved. An analysis of the distribution of somatic mutations in mutated DLBL cases has been carried out using the method by Chang and Casali.
14 In this method, the binomial distribution model is used to calculate whether the probability of an excess in CDRs or scarcity in FRs of R mutations resulted by chance alone. The results of the analysis are summarized in Table 3 . Applying the binomial distribution model, there were more R mutations in the CDRs and fewer R mutations in the FRs than expected due to chance in two of the three sequences, with significant (Po0.05) clustering.
Discussion
The characterization of V H mutational status of CLL cells may provide prognostic information for a risk-adapted management of CLL patients. To determine whether Richter's syndrome develops in CLLs that express mutated or unmutated V H genes, we have analyzed V H gene mutational status of sequential CLL and DLBL tumor samples in eight patients where Richter's syndrome developed in the course of the disease. However, the number of Richter's syndrome analyzed in this study are small; our results demonstrate that DLBL may develop in CLL patients with both mutated or unmutated V H genes, but DLBLs with unmutated V H genes are evolved from CLL tumorclone in contrast to DLBLs with mutated V H genes that developed as clonally unrelated, secondary neoplasm (Figure 1) .
The development of DLBLs in Richter's syndrome comprises two alternative pathways in a biological aspect. DLBL may evolve from pre-existing CLL tumorclone or develop as a secondary, unrelated neoplasm. 4, 7 Therefore, it has been proposed to use the term 'lymphoma progression' denoting cases where DLBL evolved from CLL, in contrast to the term 'composite lymphoma', indicating different clonal origin of CLL and DLBL tumorclones. 6 The present V H gene mutational status analysis demonstrates that the development of DLBL through 'lymphoma progression' occurred only in CLL patents with unmutated V H genes. Unmutated CLLs frequently carry distinct genomic aberrations such as trisomy 12 and 17p and 11q deletions. [15] [16] [17] These abnormalities also have been reported in transformed DLBL clones; however, other genetic abnormalities were also associated with Richter's transformation at both , diffuse large B-cell lymphoma; R, number of detected and (expected) R mutations; S, number of detected S mutations; P-value, probability. *, Statistically significant. 18, 19 These findings suggest that CLLs with unmutated V H genes may undergo clonal evolution in which accumulation of different chromosomal and molecular abnormalities results in the evolution of the DLBL tumorclone. Interestingly, the other type of low-grade NHLs with unmutated V H genes may transform to DLBL. Camacho et al 20 reported four cases of splenic marginal zone lymphoma with unmutated V H genes that transformed to DLBL further, suggesting that tumor clones with unmutated V H genes are prone to clonal evolution and morphologic transformation.
Unmutated CLLs that transformed to DLBLs used the V H 1-02, V H 1-08, V H 1-24 and V H 3-11 genes ( Table 2 ). The occurrence of these V H genes are relatively low or absent in the group of unmutated CLLs. 2, 21 Interestingly, none of the cases expressed the V H 1-69 gene, which is the most frequently used gene in unmutated CLLs. 2, 21 However, the number of cases analyzed in this study is relatively low for a conclusion of the preferential use of genes in clonal transformation of CLLs, but the absence of the expression of genes that are preferentially used by unmutated CLLs suggests that Richter's transformation may be related to different subsets of unmutated CLLs.
Reports of V H gene analysis indicate that individual CLL patients do not change their mutational status during the clinical course of the disease. 22 However, using the highly sensitive cDNA single-strand conformation polymorphism analyses, Gurrieri et al 23 demonstrated that the somatic mutation mechanism remains functional in CLL cells and may play a role in the evolution of the tumor clone. This intraclonal microheterogeneity was even detected in CLLs with unmutated subtypes. The tumor samples of patients with Richter's transformation analyzed in this study demonstrate that during the histological transformation of CLL, the V H gene mutational status remained stable and the mutational mechanism was not activated in Richter's transformation.
In three of the eight cases with Richter's syndrome, the DLBL developed as secondary independent lymphoma, also designed as 'composite lymphoma'. These DLBLs developed in both CLL cases whose tumor cells displayed mutated or unmutated V H genes, but all the secondary DLBLs expressed mutated V H genes with no evidence of intraclonal heterogeneity. The mutated V H gene status in these lymphomas is consistent with the findings that secondary DLBLs develop from germinal center experienced B cells; however, the CD5 expression in these cases suggests a unique way of pathogenesis. CD5-positive DLBL may also develop 'de novo' without a prior history of CLL. 24 The similar patterns of V H gene mutations found in de novo CD5-positive DLBLs and DLBLs developed in Richter's syndrome as secondary unrelated neoplasm suggests that both lymphomas derived from a CD5-positive B cells that express stable mutated V H genes. 25, 26 B-cell malignancies are considered to arise from normal lymphocytes at different stages of B-cell differentiation. Gene expression profiling of DLBLs has revealed two distinct tumor subtypes. One subgroup closely resembled normal germinal center B cells in gene expression, and others expressed genes that are characteristic of activated B cells. 27 These two subtypes of DLBLs also express Ig genes with different patterns of somatic mutations. DLBLs with germinal center cell-like gene expression profile show ongoing mutations in their Ig genes in contrast to DLBLs with activated B-cell-like expression profile where Ig genes mutations are associated with no evidence of ongoing nature. 28, 29 Mutated V H genes without intraclonal heterogeneity found in DLBLs developed as a secondary neoplasm in Richter's syndrome suggest an activated B-cell origin, but unmutated V H gene configuration in DLBLs transformed from CLL tumorclone is a rare finding in the group of DLBLs. 28, 29 These data raise the possibility that DLBLs developed as clonal transformation of CLLs represent an additional unique subgroup of DLBLs that differ from de novo DLBLs in their biological nature and clinical behavior.
In summary, our findings suggest that DLBLs developing as clonal transformation of CLLs and DLBLs arising as secondary unrelated neoplasm in patients with CLLs represent different subgroups of DLBLs that differ in cellular origin. These findings also suggest that different pathways of Richter's syndrome can be associated with neoplastic transformation of different B-cell subpopulation.
